Annual Total Liabilities
$18.23 M
+$1.77 M+10.78%
December 31, 2024
Summary
- As of March 6, 2025, JSPR annual total liabilities is $18.23 million, with the most recent change of +$1.77 million (+10.78%) on December 31, 2024.
- During the last 3 years, JSPR annual total liabilities has fallen by -$5.91 million (-24.49%).
- JSPR annual total liabilities is now -68.84% below its all-time high of $58.49 million, reached on December 31, 2020.
Performance
JSPR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$18.23 M
+$2.49 M+15.84%
December 31, 2024
Summary
- As of March 6, 2025, JSPR quarterly total liabilities is $18.23 million, with the most recent change of +$2.49 million (+15.84%) on December 31, 2024.
- Over the past year, JSPR quarterly total liabilities has increased by +$2.49 million (+15.84%).
- JSPR quarterly total liabilities is now -68.84% below its all-time high of $58.49 million, reached on December 31, 2020.
Performance
JSPR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
JSPR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.8% | +15.8% |
| 3 y3 years | -24.5% | +12.0% |
| 5 y5 years | -68.8% | +12.0% |
JSPR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.5% | +47.3% | -24.5% | +57.9% |
| 5 y | 5-year | -68.8% | +47.3% | -68.8% | +57.9% |
| alltime | all time | -68.8% | +47.3% | -68.8% | +57.9% |
Jasper Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $18.23 M(+10.8%) | $18.23 M(+15.8%) |
| Sep 2024 | - | $15.73 M(+15.5%) |
| Jun 2024 | - | $13.62 M(+7.0%) |
| Mar 2024 | - | $12.73 M(-22.6%) |
| Dec 2023 | $16.45 M | $16.45 M(+1.1%) |
| Sep 2023 | - | $16.27 M(+16.5%) |
| Jun 2023 | - | $13.96 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $13.56 M(+9.6%) |
| Dec 2022 | $12.37 M(-48.7%) | $12.37 M(+7.2%) |
| Sep 2022 | - | $11.54 M(-0.3%) |
| Jun 2022 | - | $11.59 M(-6.9%) |
| Mar 2022 | - | $12.44 M(-48.4%) |
| Dec 2021 | $24.14 M(-58.7%) | $24.14 M(-15.6%) |
| Sep 2021 | - | $28.61 M(-51.1%) |
| Dec 2020 | $58.49 M | $58.49 M |
FAQ
- What is Jasper Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics annual total liabilities year-on-year change?
- What is Jasper Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly total liabilities year-on-year change?
What is Jasper Therapeutics annual total liabilities?
The current annual total liabilities of JSPR is $18.23 M
What is the all time high annual total liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high annual total liabilities is $58.49 M
What is Jasper Therapeutics annual total liabilities year-on-year change?
Over the past year, JSPR annual total liabilities has changed by +$1.77 M (+10.78%)
What is Jasper Therapeutics quarterly total liabilities?
The current quarterly total liabilities of JSPR is $18.23 M
What is the all time high quarterly total liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly total liabilities is $58.49 M
What is Jasper Therapeutics quarterly total liabilities year-on-year change?
Over the past year, JSPR quarterly total liabilities has changed by +$2.49 M (+15.84%)